These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26135712)
1. Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi. Mo Z; Li H; Huang L; Jiao W Transfus Med; 2015 Oct; 25(5):313-9. PubMed ID: 26135712 [TBL] [Abstract][Full Text] [Related]
2. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Tormey CA; Fisk J; Stack G Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165 [TBL] [Abstract][Full Text] [Related]
3. RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital. Erikstein BS; Hagen KG; Hervig T Transfus Med; 2019 Jun; 29(3):169-178. PubMed ID: 29377396 [TBL] [Abstract][Full Text] [Related]
4. Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients. Xu P; Li Y; Yu H Blood Transfus; 2014 Jan; 12(1):56-60. PubMed ID: 24333071 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Natukunda B; Schonewille H; van de Watering L; Brand A Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889 [TBL] [Abstract][Full Text] [Related]
6. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Cheng CK; Lee CK; Lin CK Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Smith HM; Shirey RS; Thoman SK; Jackson JB Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681 [TBL] [Abstract][Full Text] [Related]
8. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management]. Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386 [TBL] [Abstract][Full Text] [Related]
9. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030 [TBL] [Abstract][Full Text] [Related]
10. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population. Garg N; Sharma T; Singh B Transfus Apher Sci; 2014 Jun; 50(3):415-7. PubMed ID: 24797241 [TBL] [Abstract][Full Text] [Related]
12. Frequency of red blood cell alloantibody in Kuwaiti population. Ameen R; Al-Eyaadi O; Al-Shemmari S; Chowdhury R; Al-Bashir A Med Princ Pract; 2005; 14(4):230-4. PubMed ID: 15961931 [TBL] [Abstract][Full Text] [Related]
13. Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan. Chao YH; Wu KH; Lu JJ; Shih MC; Peng CT; Chang CW Blood Transfus; 2013 Jan; 11(1):71-4. PubMed ID: 22790261 [TBL] [Abstract][Full Text] [Related]
14. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and Specificity of Red Blood Cell Alloantibodies in Patients from China During 1994-2013. Yu Y; Wang Y; Sun XL; Ma CY; Zhang XJ; Guan XZ; Chen LF; Wang DQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1734-41. PubMed ID: 26708902 [TBL] [Abstract][Full Text] [Related]
16. Is it reasonable for the use of Rh-ee blood? A hospital-based survey from a southern medical center in Taiwan. Hsiao HH; Yeh CJ; Ting SC; Chuang TM; Ke YL; Yeh TJ; Gau YC; Du JS; Hsiao CE; Wang HC; Cho SF; Hsu CM; Liu YC Kaohsiung J Med Sci; 2022 Jan; 38(1):65-69. PubMed ID: 34647681 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. Watson WJ; Wax JR; Miller RC; Brost BC Am J Perinatol; 2006 Apr; 23(3):189-92. PubMed ID: 16586229 [TBL] [Abstract][Full Text] [Related]
18. Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome. Rozovski U; Ben-Tal O; Kirgner I; Mittelman M; Hareuveni M Isr Med Assoc J; 2015 Oct; 17(10):624-7. PubMed ID: 26665317 [TBL] [Abstract][Full Text] [Related]
19. A novel association between high red blood cell alloimmunization rates and hereditary hemorrhagic telangiectasia. Zheng Y; Pollak J; Henderson K; Hendrickson JE; Tormey CA Transfusion; 2018 Mar; 58(3):775-780. PubMed ID: 29210083 [TBL] [Abstract][Full Text] [Related]
20. The Prevalence of Red Blood Cell Alloantibodies in Lower Northern Thailand. Po-ngernnak P; Sasjeenpong S; Chuesakul K; Pangwangthong K J Med Assoc Thai; 2016 Dec; 99(12):1337-43. PubMed ID: 29952524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]